Condition: Critical Illness · Sponsor: Scarborough General Hospital
In patients with critical illness, such as severe infections, heart attacks, or respiratory failure, most intensive care units (ICUs) measure magnesium levels and give supplemental doses of magnesium when levels are below certain targets. However, the best targets are unknown. The goal of this clinical trial is to study protocols for magnesium supplementation in people with critical illness, comparing a protocol with higher target level to a protocol with a lower target level. The main question this study aims to answer is whether magnesium supplementation protocols targeting a higher or lower level lead to better 30-day survival and less atrial fibrillation. Participants will not have to do any specific tasks, undergo any additional tests, or complete any surveys.
This description comes directly from the study's public registry record.
Joshua Craig · 4164382911 · jcraig@shn.ca
Always discuss trial participation with your own doctor first.
| Lakeridge Health Ajax-Pickering | Ajax, Ontario, Canada | Recruiting |
| Lakeridge Health Bowmanville | Bowmanville, Ontario, Canada | Recruiting |
| Lakeridge Health Oshawa | Oshawa, Ontario, Canada | Recruiting |
| Scarborough Centenary Hospital | Toronto, Ontario, Canada | Recruiting |
| Scarborough General Hospital | Toronto, Ontario, Canada | Recruiting |
| Scarborough Birchmount Hospital | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07173855